LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
61.95 USD
-0.74%
Updated:
May 10, 2024
LivaNova PLC
Accrued Liabilities
|
LivaNova PLC
Accrued Liabilities Peer Comparison
Comparables:
SN
LMDX
EKF
AGL
CREO
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Accrued Liabilities
$174.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
23%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Accrued Liabilities
$31.1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Angle PLC
LSE:AGL
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Accrued Liabilities
£3.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Accrued Liabilities?
Accrued Liabilities
174.2m
USD
174.2m
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Accrued Liabilities amounts to 174.2m USD.
What is LivaNova PLC's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
23%
23%
Over the last year, the Accrued Liabilities growth was 13%. The average annual Accrued Liabilities growth rates for LivaNova PLC have been 8% over the past three years , -6% over the past five years , and 23% over the past ten years .
You don't have any saved screeners yet
